Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging
2024

Targeted Nanoparticles for Colorectal Cancer Imaging

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chung Seock-Jin, Hadrick Kay, Nafiujjaman Md, Apu Ehsanul Hoque, Hill Meghan L., Nurunnabi Md, Contag Christopher H., Kim Taeho

Primary Institution: Michigan State University

Hypothesis

Can targeted near-infrared fluorescent silica nanoparticles improve the detection of colorectal cancer?

Conclusion

The study demonstrates that CEA-FSNs can effectively target and image colorectal cancer cells, indicating their potential as a diagnostic tool.

Supporting Evidence

  • CEA-FSNs showed significantly greater binding to CEA-positive HT29 cells compared to CEA-negative HCT116 cells.
  • Smaller CEA-FSNs were internalized more efficiently into HT29 cells than larger ones.
  • NIRF imaging revealed a twofold increase in signal intensity in CEA-positive tumors compared to CEA-negative tumors.
  • Immunofluorescence confirmed that CEA-FSNs co-registered with CRC markers in excised tissue.

Takeaway

Scientists created tiny particles that can help doctors see cancer in the intestines better, making it easier to find and treat early.

Methodology

The study involved synthesizing near-infrared fluorescent silica nanoparticles, testing their binding to colorectal cancer cells, and imaging in rodent models.

Limitations

The study primarily focused on rodent models, which may not fully represent human responses.

Participant Demographics

The study used human colorectal cancer cell lines and rodent models.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1021/acsabm.4c00072

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication